Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio B González

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medgenmed : Medscape General Medicine|December 31, 2005
Readers' responses to "why should physicians be underlings?"Emilio B González
Current Opinion in Hematology|August 5, 2006
Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanismsSilvia S Pierangeli, Pojen P Chen, Emilio B González
Expert Reviews in Molecular Medicine|November 14, 2007
New targeted therapies for treatment of thrombosis in antiphospholipid syndromeSilvia S Pierangeli, Mariano E Vega-Ostertag, Emilio B González
Annals of the Rheumatic Diseases|August 13, 2013
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patientsDoruk Erkan, Rohan Willis, Vijaya L Murthy, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medgenmed : Medscape General Medicine|December 31, 2005
Readers' responses to "why should physicians be underlings?"Emilio B González
Current Opinion in Hematology|August 5, 2006
Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanismsSilvia S Pierangeli, Pojen P Chen, Emilio B González
Expert Reviews in Molecular Medicine|November 14, 2007
New targeted therapies for treatment of thrombosis in antiphospholipid syndromeSilvia S Pierangeli, Mariano E Vega-Ostertag, Emilio B González
Annals of the Rheumatic Diseases|August 13, 2013
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patientsDoruk Erkan, Rohan Willis, Vijaya L Murthy, et al.
Pageof 1